Sobre a EDCTP
We are in the process of launching our new website. Please come back later to check it out.
A Parceria entre a Europa e os Países em Desenvolvimento para a Realização de Ensaios Clínicos (EDCTP) tem por objectivo acelerar o desenvolvimento de fármacos, vacinas, microbicidas e diagnósticos novos ou melhorados para o VIH/SIDA, a tuberculose e a malária, com particular incidência em ensaios clínicos da fase II e III na África subsaariana.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Portuguese title
Descubra a estratégia da EDCTP na luta contra HIV/AIDS, tuberculose e malária.
Latest news
PredART trial shows TB-IRIS can be prevented in patients with HIV-TB co-infection
The results of the PredART clinical trial co-funded by EDCTP were published in the New England Journal of Medicine on 14 November 2018. Prof. Graeme Meintjes (University of Cape Town) and his team showed that a moderate dose of prednisone…
EDCTP and Wellcome Trust organise session at ASTMH 2018
EDCTP and the Wellcome Trust organised a session on controlled Human Infection Studies in low- and middle-income countries as a contribution to the ASTMH 2018 programme. The symposium (session 169) takes place on 1 November from 08:00-09:45. The annual meeting…